ArticleOncogene2005

ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.

Asa Kronblad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.